Humana Inc vs State Street Technology Select Sector SPDR ETF — how do they compare? Humana Inc trades at $433.13 (market cap $46.49B), while State Street Technology Select Sector SPDR ETF trades at $198.04 (market cap $132.55B). The key difference: State Street Technology Select Sector SPDR ETF is far larger — about 2.9× Humana Inc's market cap, and Humana Inc pays a 0.91% dividend while State Street Technology Select Sector SPDR ETF pays none. Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and State Street Technology Select Sector SPDR ETF for 49 Days on average.
| HUM | XLK | |
|---|---|---|
Market Cap | $46.49B | $132.55B |
Volume | 2,567,704 | 9,063,135 |
Sector | Health | Sector/Thematic |
52-Week High | $409.85 | $202.00 |
52-Week Low | $163.67 | $127.49 |
Typical Hold Time | 53 Days | 49 Days |
Enterprise Value | $53.84B | — |
Dividend Yield | 0.91% | — |
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $441.74, up 11.41% over 24 hours, reflecting strong momentum. The stock shows bullish technical signals with support at $391 and resistance at $406. Fundamentally, revenue grew to $129.66B in 2025, though net income margin compressed to 0.88%. Recent news highlights a Barclays upgrade to a $515 price target and upcoming Q3 earnings on November 6, 2026.
The outlook is cautiously optimistic with a consensus price target of $457.05 implying modest upside. Risks include margin pressure from Medicare Advantage plan changes and potential regulatory scrutiny. Institutional activity is mixed, with Bank of America adding a position while some funds reduced stakes.
XLK trades at $201.39, down 0.3% on the day, with a bullish technical signal from moving averages but overbought RSI readings. The ETF holds near its pivot point of $201, with support at $200 and resistance at $202. Recent news highlights concentration risks in semiconductor holdings and comparisons with alternative tech ETFs.
Outlook remains cautiously optimistic given strong technical momentum, though high RSI suggests near-term consolidation. Risks include sector concentration and interest rate sensitivity. Analyst sentiment is mixed, weighing AI growth potential against valuation concerns after recent gains.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →XLK tracks the Technology Select Sector Index, providing targeted exposure to the largest and most influential technology companies within the S&P 500. It is a highly concentrated, liquid vehicle focused on software, semiconductors, and hardware leaders, serving as the primary benchmark for U.S. large-cap technology performance.
Read more on XLK →